Imprimed Raises $23 Million Series A Round To Expand Its Revolutionary Ai-Powered Cancer Treatment Technology
Amount Raised
$23 Million
Round Type
Series A
Mountain ViewBiotechnologyHealth CareArtificial IntelligenceMedicalHealth DiagnosticsInvestors
Description
ImpriMed, a leading precision medicine startup focused on leveraging artificial intelligence to improve cancer treatment, today announced the close of a $23 million Series A funding round, led by SBVA. HRZ Han River Partners, SK Telecom, KDB Silicon Valley, Ignite Innovation Fund, Samyang Chemical Group, Murex Partners, and Byucksan also participated in this round. The funding will enable ImpriMed to expand its revolutionary drug response prediction technology beyond veterinary medicine into human oncology, increase headcount, and broaden its business development and research and development pipeline.
Quick answer
ImpriMed raised $23 Million in a Series A round, dated December 19, 2023. Investors: Byucksan, Murex Partners, Samyang Chemical Group, Ignite Innovation Fund, KDB Silicon Valley, SK Telecom, HRZ Han River Partners and Sbva. ImpriMed is based in Mountain View, California, United States.
- How much did ImpriMed raise?
- ImpriMed raised $23 Million in a Series A round on December 19, 2023.
- Who invested in ImpriMed?
- Byucksan, Murex Partners, Samyang Chemical Group, Ignite Innovation Fund, KDB Silicon Valley, SK Telecom, HRZ Han River Partners and Sbva are named as investors in this round.
- What does ImpriMed do?
- ImpriMed provides cutting-edge personalized medicine easily accessible for pets with blood cancer diseases.
- Where is ImpriMed based and how big is it?
- ImpriMed is based in Mountain View, California, United States. Fundz records about 46 employees.
- Who are the decision-makers at ImpriMed?
- Fundz holds 1 contact at ImpriMed. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Health Diagnostics around the same time
Companies in the same sectors as ImpriMed that raised within 45 days of this round, from Fundz verified event records.
- Vektor Medical raised $29M on February 2, 2024.
- Laza Medical raised $36M (Series A) on December 12, 2023.
- Laza Medical raised $25M on November 24, 2023.
- Cohere Health raised $50M on February 1, 2024.
- Cleveland Diagnostics raised $75M (Funding Round) on January 17, 2024.
- Cleveland Diagnostics raised $56M on January 16, 2024.
Who to call at ImpriMed, and when
A new round usually means ImpriMed is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ImpriMed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ImpriMed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ImpriMed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ImpriMed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansImpriMed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.